Notice of Interest Rate on Overdue Debts, 4268 [2015-01429]
Download as PDF
<![CDATA[
asabaliauskas on DSK5VPTVN1PROD with NOTICES
4268
Federal Register / Vol. 80, No. 17 / Tuesday, January 27, 2015 / Notices
numbers above each band
representing the fold change human
prostate cancer cell lines; the numbers
above each band representing the fold
change in expression relative to the
DMSO control also were falsified for
p-ACLY (LNCaP cell line) and p-Akt
(PC3 and LNCaP cell lines) compared
to the values provided to the
Respondent
• falsified Figure 4D by substituting
bands for p-ACLY for those provided
to him to allow Respondent to claim
that Z-Gug significantly inhibited
phosphorylation of ACLY in lysates of
prostate tumors obtained from mice,
when the original data showed no
effect
• falsified Figures 5C and 5D to show
that treatment of PC3 and LNCaP cells
with Z-Gug alone and with Z-Gug
plus si-RNA targets to ACLY
stimulated Caspase 3/7 activity, when
the original data provided to him
showed no significant effect of either
treatment in PC3 cells and no effect of
Z-Gug alone in LNCaP cells
• falsified Figures 6G and 6H; these
figures purported to show that Nacetyl-L-cysteine (NAC), an inhibitor
of reactive oxygen species (ROS),
reversed the inhibition of Akt
phosphorylation caused by Z-Gug in
PC3 cells (Figure 6G) and LNCaP cells
(Figure 6G) when no Akt data for this
protocol was available to the
Respondent; Respondent admitted to
falsifying Figure 6G
• falsified Figures S2B and S3B by
altering data provided to him; these
experiments are complementary to
those shown in Figures 5C and 5D,
except that the effect of Z-Gug and Zgug plus si-RNA on Caspase 3/7
activity utilized on si-RNA was
directed to Akt activity. The original
data showed no significant effect of
either treatment in PC3 cells and no
effect of Z-Gug on LNCaP cells, while
both treatments were claimed to be
significant inducers of caspase
activity in both cell lines in the
published figures.
Dr. Xiao has entered into a Voluntary
Settlement Agreement (Agreement) and
has voluntarily agreed for a period of
three (3) years, beginning on December
23, 2014:
(1) To have his research supervised;
Respondent agreed to ensure that prior
to the submission of an application for
U.S. Public Health Service (PHS)
support for a research project on which
the Respondent’s participation is
proposed and prior to Respondent’s
participation in any capacity on PHSsupported research, the institution
employing him must submit a plan for
VerDate Sep<11>2014
18:01 Jan 26, 2015
Jkt 235001
supervision of his duties to ORI for
approval; the plan for supervision must
be designed to ensure the scientific
integrity of Respondent’s research
contribution; Respondent agreed that he
will not participate in any PHSsupported research until such a
supervision plan is submitted to and
approved by ORI; Respondent agreed to
maintain responsibility for compliance
with the agreed upon plan for
supervision;
(2) that any institution employing him
must submit, in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which
Respondent is involved, a certification
to ORI that the data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract; and
(3) to exclude himself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant.
FOR FURTHER INFORMATION CONTACT:
Acting Director, Office of Research
Integrity, 1101 Wootton Parkway, Suite
750, Rockville, MD 20852, (240) 453–
8200.
Donald Wright,
Acting Director, Office of Research Integrity.
[FR Doc. 2015–01427 Filed 1–26–15; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Notice of Interest Rate on Overdue
Debts
Section 30.18 of the Department of
Health and Human Services’ claims
collection regulations (45 CFR part 30)
provides that the Secretary shall charge
an annual rate of interest, which is
determined and fixed by the Secretary
of the Treasury after considering private
consumer rates of interest on the date
that the Department of Health and
Human Services becomes entitled to
recovery. The rate cannot be lower than
the Department of Treasury’s current
value of funds rate or the applicable rate
determined from the ‘‘Schedule of
Certified Interest Rates with Range of
Maturities’’ unless the Secretary waives
interest in whole or part, or a different
rate is prescribed by statute, contract, or
repayment agreement. The Secretary of
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
the Treasury may revise this rate
quarterly. The Department of Health and
Human Services publishes this rate in
the Federal Register.
The current rate of 101⁄2%, as fixed by
the Secretary of the Treasury, is certified
for the quarter ended December 31,
2014. This rate is based on the Interest
Rates for Specific Legislation, ‘‘National
Health Services Corps Scholarship
Program (42 U.S.C. 250(B)(1)(A))’’ and
‘‘National Research Service Award
Program (42 U.S.C. 288(c)(4)(B)).’’ This
interest rate will be applied to overdue
debt until the Department of Health and
Human Services publishes a revision.
Dated: January 15, 2015.
David C. Horn,
Director, Office of Financial Policy and
Reporting.
[FR Doc. 2015–01429 Filed 1–26–15; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service (DHHS) is hereby giving notice
that the Presidential Advisory Council
on HIV/AIDS (PACHA) will hold a
meeting to discuss essential health
benefits and provider networks, the
integration of the Affordable Care Act
(ACA) qualified health plan and the
Ryan White Program; an update on the
National HIV/AIDS Strategy; and a
discussion on surveillance data. The
meeting will be open to the public.
DATES: The meeting will be held on
February 12, 2015, from 9 a.m. to
approximately 5 p.m. (ET) and February
13, 2015, from 9:30 a.m. to
approximately 12:30 p.m. (ET).
ADDRESSES: Renaissance Washington
DC, Downtown Hotel, 999 Ninth Street
NW., Washington, DC 20001.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, Public Health Analyst,
Presidential Advisory Council on HIV/
AIDS, U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 443H, Washington,
DC 20201; (202) 205–1178. More
detailed information about PACHA can
be obtained by accessing the PACHA
Web page on the AIDS.Gov Web site at
www.aids.gov/pacha.
SUMMARY:
E:\FR\FM\27JAN1.SGM
27JAN1
]]>Agencies
[Federal Register Volume 80, Number 17 (Tuesday, January 27, 2015)]
[Notices]
[Page 4268]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01429]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Notice of Interest Rate on Overdue Debts
Section 30.18 of the Department of Health and Human Services'
claims collection regulations (45 CFR part 30) provides that the
Secretary shall charge an annual rate of interest, which is determined
and fixed by the Secretary of the Treasury after considering private
consumer rates of interest on the date that the Department of Health
and Human Services becomes entitled to recovery. The rate cannot be
lower than the Department of Treasury's current value of funds rate or
the applicable rate determined from the ``Schedule of Certified
Interest Rates with Range of Maturities'' unless the Secretary waives
interest in whole or part, or a different rate is prescribed by
statute, contract, or repayment agreement. The Secretary of the
Treasury may revise this rate quarterly. The Department of Health and
Human Services publishes this rate in the Federal Register.
The current rate of 10\1/2\%, as fixed by the Secretary of the
Treasury, is certified for the quarter ended December 31, 2014. This
rate is based on the Interest Rates for Specific Legislation,
``National Health Services Corps Scholarship Program (42 U.S.C.
250(B)(1)(A))'' and ``National Research Service Award Program (42
U.S.C. 288(c)(4)(B)).'' This interest rate will be applied to overdue
debt until the Department of Health and Human Services publishes a
revision.
Dated: January 15, 2015.
David C. Horn,
Director, Office of Financial Policy and Reporting.
[FR Doc. 2015-01429 Filed 1-26-15; 8:45 am]
BILLING CODE 4150-04-P
